Andrea Newkirk
Stock Analyst at Goldman Sachs
(3.01)
# 1,319
Out of 5,122 analysts
4
Total ratings
100%
Success rate
92.55%
Average return
Main Sectors:
Stocks Rated by Andrea Newkirk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Initiates: Neutral | $19 | $13.36 | +42.22% | 1 | Sep 30, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $73 | $96.51 | -24.36% | 2 | Sep 12, 2025 | |
| ALKS Alkermes | Initiates: Buy | $43 | $34.13 | +25.99% | 1 | Jul 15, 2025 |
Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $13.36
Upside: +42.22%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65 → $73
Current: $96.51
Upside: -24.36%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $34.13
Upside: +25.99%